- Home
- ADIL vs DSS Comparison
ADIL vs DSS Comparison
Compare ADIL & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADIL
- DSS
- Stock Information
- Founded
- ADIL 2010
- DSS 1984
- Country
- ADIL United States
- DSS United States
- Employees
- ADIL N/A
- DSS N/A
- Industry
- ADIL Biotechnology: Pharmaceutical Preparations
- DSS Containers/Packaging
- Sector
- ADIL Health Care
- DSS Consumer Discretionary
- Exchange
- ADIL Nasdaq
- DSS Nasdaq
- Market Cap
- ADIL 6.5M
- DSS 7.3M
- IPO Year
- ADIL 2018
- DSS N/A
- Fundamental
- Price
- ADIL $0.96
- DSS $0.86
- Analyst Decision
- ADIL Strong Buy
- DSS
- Analyst Count
- ADIL 1
- DSS 0
- Target Price
- ADIL $8.00
- DSS N/A
- AVG Volume (30 Days)
- ADIL 86.8K
- DSS 36.0K
- Earning Date
- ADIL 11-13-2024
- DSS 11-13-2024
- Dividend Yield
- ADIL N/A
- DSS N/A
- EPS Growth
- ADIL N/A
- DSS N/A
- EPS
- ADIL N/A
- DSS N/A
- Revenue
- ADIL N/A
- DSS $25,019,000.00
- Revenue This Year
- ADIL N/A
- DSS N/A
- Revenue Next Year
- ADIL N/A
- DSS N/A
- P/E Ratio
- ADIL N/A
- DSS N/A
- Revenue Growth
- ADIL N/A
- DSS N/A
- 52 Week Low
- ADIL $0.77
- DSS $0.81
- 52 Week High
- ADIL $4.17
- DSS $2.30
- Technical
- Relative Strength Index (RSI)
- ADIL 37.57
- DSS 42.21
- Support Level
- ADIL $0.99
- DSS $0.89
- Resistance Level
- ADIL $1.06
- DSS $0.99
- Average True Range (ATR)
- ADIL 0.06
- DSS 0.08
- MACD
- ADIL -0.01
- DSS -0.00
- Stochastic Oscillator
- ADIL 0.00
- DSS 0.00
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.
About DSS DSS Inc.
DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia.